Cargando…
Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) is a prevalent malignancy with a rising incidence in developing countries. Clear cell renal cell carcinoma (ccRCC) constitutes 70% of RCC cases and is prone to metastasis and recurrence, yet lacks a liquid biomarker for surveillance. Extracellular vesicles (EVs...
Autores principales: | Xue, Yizheng, Chen, Tianyi, Hou, Naiqiao, Wu, Xiaorong, Kong, Wen, Huang, Jiwei, Zhang, Jin, Chen, Yonghui, Zheng, Junhua, Zhai, Wei, Xue, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307730/ https://www.ncbi.nlm.nih.gov/pubmed/37380801 http://dx.doi.org/10.1007/s12672-023-00730-2 |
Ejemplares similares
-
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022) -
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2022) -
Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021) -
Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value
por: Zhou, Jiale, et al.
Publicado: (2021) -
Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease
por: Dias, Francisca, et al.
Publicado: (2020)